Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats

Life Sciences

Volumn 91, Issue 13-14, 2012, Pages 644-650

  Kimura, Kimihiro ^a   Ohkita, Mamoru ^a   Koyama, Maki ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

DOCA salt; Endothelin 1; ETA receptor; NF B; Nitric oxide

Indexed keywords

CREATININE; DEOXYCORTICOSTERONE ACETATE; DRINKING WATER; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N(G) NITROARGININE; NITRATE; NITRIC OXIDE; NITRITE; PYRROLIDINE DITHIOCARBAMATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DISEASE SEVERITY; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; NONHUMAN; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENDOTHELIN-1; HYPERTENSION; KIDNEY DISEASES; MALE; NF-KAPPA B; NITRIC OXIDE; NITROARGININE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; SEVERITY OF ILLNESS INDEX; SODIUM CHLORIDE, DIETARY; THIOCARBAMATES;

RATTUS;

EID: 84867579516     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.04.022     Document Type: Conference Paper

References (48)

1. S. Aiello, M. Noris, M. Todeschini, S. Zappella, C. Foglieni, and A. Benigni Renal and systemic nitric oxide synthesis in rats with renal mass reduction Kidney Int 52 1997 171 181
2. G.H. Allcock, M. Hukkanen, J.M. Polak, J.S. Pollock, and D.M. Pollock Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats J Am Soc Nephrol 10 1999 2283 2289
3. G. Alvarez, A. Osuna, R. Wangensteen, and F. Vargas Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure Hypertension 35 2000 752 757
4. A receptors Hypertension 39 2002 679 684
5. C. Baylis Nitric oxide deficiency in chronic kidney disease Am J Physiol Renal Physiol 294 2008 F1 F9
6. R.A. Beswick, H. Zhang, D. Marable, J.D. Catravas, W.D. Hill, and R.C. Webb Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response Hypertension 37 2001 781 786
7. N. Dhaun, J. Goddard, and D.J. Webb The endothelin system and its antagonism in chronic kidney disease J Am Soc Nephrol 17 2006 943 955
8. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
9. A. Erdely, G. Freshour, D.A. Maddox, J.L. Olson, L. Samsell, and C. Baylis Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production Diabetologia 47 2004 1672 1676
10. A. Erdely, G. Freshour, Y.L. Tain, K. Engels, and C. Baylis DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains Am J Physiol Renal Physiol 292 2007 F192 F196
11. M. Foschi, A. Sorokin, P. Pratt, A. McGinty, G. La Villa, and F. Franchi Preproendothelin-1 expression in human mesangial cells: evidence for a p38 mitogen-activated protein kinase/protein kinases-C-dependent mechanism J Am Soc Nephrol 12 2001 1137 1150
12. C.K. Fujihara, G.R. Antunes, A.L. Mattar, D.M. Malheiros, J.M. Vieira Jr., and R. Zatz Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model Am J Physiol Renal Physiol 292 2007 F92 F99
13. D. Fulton, J.P. Gratton, T.J. McCade, J. Fontana, Y. Fujio, and K. Walsh Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
14. J. Goddard, N.R. Johnston, M.F. Hand, A.D. Cumming, T.J. Rabelink, and A.J. Rankin Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade Circulation 109 2004 1186 1193
15. M.C. Gracia, A. Osuna, F. O'Valle, R.G. del Moral, R. Wangensteen, and C.G. del Rio Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats J Am Soc Nephrol 11 2000 1995 2000
16. H. Hayakawa, Y. Hirata, E. Suzuki, K. Kimura, K. Kikuchi, and T. Nagano Long-term administration of l-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats Hypertension 23 1994 752 756
17. W.H. Herman, S.N. Emancipator, R.L. Rhoten, and M.S. Simonson Vascular and glomerular expression of endothelin-1 in normal human kidney Am J Physiol 275 1998 F8 F17
18. M. Herrera, G. Silva, and J.L. Garvin A high-salt diet dissociates NO synthase-3 expression and NO production by the thick ascending limb Hypertension 47 2006 95 101
19. T.J. Hsieh, S.R. Lin, Y.J. Lee, S.J. Shin, Y.H. Lai, and C.H. Hsu Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats Am J Physiol Renal Physiol 279 2000 F112 F121
20. M. Kakoki, A.P. Zou, and D.L. Mattson The influence of nitric oxide synthase 1 on blood flow and interstitial nitric oxide in the kidney Am J Physiol Regul Integr Comp Physiol 281 2001 R91 R97
21. K. Katsuyama, M. Shichiri, F. Marumo, and Y. Hirata NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α Arterioscler Thromb Vasc Biol 18 1998 1796 1802
22. B receptor, is protective against ischemic acute renal failure in rats Jpn J Pharmacol 82 2000 307 316
23. M. Martínez-Maldonado Role of hypertension in the progression of chronic renal disease Nephrol Dial Transplant 16 2001 63 66
24. Y. Matsumura, N. Hashimoto, S. Taira, T. Kuro, R. Kitano, and M. Ohkita Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats Hypertension 33 1999 759 765
25. Y. Matsumura, T. Kuro, Y. Kobayashi, F. Konishi, M. Takaoka, and J.L. Wessale Ezaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension Circulation 102 2000 2765 2773
26. Z. Miloradović, D. Jovović, N. Mihailović- Stanojević, J.G. Milanović, and S. Milanović Effects of long-term losartan and l-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats Can J Physiol Pharmacol 86 2008 210 214
27. P.F. Mount, B.E. Kemp, and D.A. Power Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation J Mol Cell Cardiol 42 2007 271 279
28. B receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension J Cardiovasc Pharmacol 44 2004 187 191
29. M. Ohkita, M. Takaoka, Y. Kobayashi, E. Itoh, H. Uemachi, and Y. Matsumura Involvement of proteasome in endothelin-1 production in cultured vascular endothelial cells Jpn J Pharmacol 88 2002 197 205
30. M. Ohkita, M. Takaoka, Y. Shiota, R. Nojiri, M. Sugii, and Y. Matsumura A nuclear factor-κB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells Jpn J Pharmacol 89 2002 81 84
31. M. Ohkita, M. Takaoka, M. Sugii, Y. Shiota, R. Nojiri, and Y. Matsumura The role of nuclear factor-kappa B in the regulation of endothelin-1 production by nitric oxide Eur J Pharmacol 472 2003 159 164
32. B receptor in partial ablation-induced chronic renal failure in rats Eur J Pharmacol 494 2004 63 71
33. H. Ono, Y. Ono, and E.D. Frohlich l-arginine reverses severe nephrosclerosis in aged spontaneously hypertensive rats J Hypertens 17 1999 121 128
34. P. Quehenberger, A. Bierhaus, P. Fasching, C. Muellner, M. Klevesath, and M. Hong Endothelin 1 transcription is controlled by nuclear factor-κB in age-stimulated cultured endothelial cells Diabetes 49 2000 1561 1570
35. A. Roczniak, J.N. Fryer, D.Z. Levine, and K.D. Burns Downregulation of neuronal nitric oxide synthase in the rat remnant kidney J Am Soc Nephrol 10 1999 704 713
36. I. Rodriguez-Gomez, R. Wangensteen, N.M. Atucha, F. O'Valle, R.G. Del Moral, and J. Garcia-Estañ Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats Am J Hypertens 16 2003 33 38
37. B. Rodríguez-Iturbe, A. Ferrebuz, V. Vanegas, Y. Quiroz, S. Mezzano, and N.D. Vaziri Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats J Pharmacol Exp Ther 315 2005 51 57
38. A. Satake, M. Takaoka, M. Nishikawa, M. Yuba, Y. Shibata, and K. Okumura Protective effect of 17β-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway Kidney Int 73 2008 308 317
39. R.J. Schmidt, and C. Baylis Total nitric oxide production is low in patients with chronic renal disease Kidney Int 58 2000 1261 1266
40. R.J. Schmidt, S. Yokota, T.S. Tracy, M.I. Sorkin, and C. Baylis Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis Am J Physiol 276 1999 F794 F797
41. T. Slowinski, P. Kalk, M. Christian, F. Schmager, K. Relle, and M. Godes Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice J Physiol 581 2007 1173 1181
42. P.P. Tak, and G.S. Firestein NF-κB: a key role in inflammatory diseases J Clin Invest 107 2001 7 11
43. A. Tedgui, and Z. Mallat Anti-inflammatory mechanisms in the vascular wall Circ Res 88 2001 877 887
44. P.L. Tharaux, C. Chatziantoniou, D. Casellas, L. Fouassier, R. Ardaillou, and J.C. Dussaule Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats Circulation 99 1999 2185 2191
45. R. Wever, P. Boer, M. Hijmering, E. Stroes, M. Verhaar, and J. Kastelein Nitric oxide production is reduced in patients with chronic renal failure Arterioscler Thromb Vasc Biol 19 1999 1168 1172
46. J. Yamashita, M. Ogata, M. Itoh, H. Yamasowa, Y. Shimeda, and M. Takaoka Role of nitric oxide in the renal protective effects of ischemic preconditioning J Cardiovasc Pharmacol 42 2003 419 427
47. C. Yamashita, N. Tazawa, M. Ohkita, and Y. Matsumura Exaggerated renal pathology of partial ablation-induced chronic renal failure in eNOS deficient mice Biol Pharm Bull 31 2008 1029 1031
48. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415